.jpg)
thumb|upright=1.3|US Officials deliver COVID-19 vaccines to Ghana as part of the COVAX program in 2021. Ghana was the first recipient of vaccines through COVAX.
thumb|upright=1.3|US Officials deliver COVID-19 vaccines to Ghana as part of the COVAX program in 2021. Ghana was the first recipient of vaccines through COVAX.
COVID-19 Vaccines Global Access, abbreviated as COVAX, was a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO), alongside key delivery partner UNICEF. It was one of the four pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinated international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF was the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well as logistics, country readiness and in-country delivery.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).